About
Acasă
In the current negotiations for Deep and Comprehensive Free Trade Area Agreement, the European Union (EU) requires the Republic of Moldova to introduce in the national legislation data exclusivity as a new form of intellectual property protection. Data exclusivity would allow pharmaceutical companies to hold exclusive rights over their clinical test data for a defined period of time. In essence, this measure ensures the exclusive right and market monopoly of originator drugs for a maximum of 11 years and the European Union promotes this measure to return initial investments that lead to discovering an innovative pharmaceutical entity. To support its position, the European Union brings several arguments that are discussed below in this document.
The Center for Health Policies and Studies (PAS Center) is an independent, non-profit organization from Moldova, implementing programs at national and regional level. Our statutory mission is to improve the health and social sector through policy advocacy and evaluation, capacity building and reform support. The PAS Center’s portfolio covers a wide range of public health programs in health systems, communicable and non-communicable diseases and social accountability programs, with a dedicated watchdog capacity. The regional activities include contributing to people-centered health system transformation in 11 countries from Eastern Europe and Central Asia: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine and Uzbekistan. The PAS Center hosts the platform E-Sanatate.md which includes a network of online products with social utility, including the site Sanatate INFO – a stakeholder-driven media outlet focusing on health issues and reforms.